Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Orlistat
Therapeutic Area : Nutrition and Weight Loss
Study Phase : Undisclosed
Recipient : University of Campinas, Brazil
Deal Size : Inapplicable
Deal Type : Inapplicable
Orlistat Induced Modulation on the Fatty Acid Composition in Obese Females
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
August 11, 2011
Lead Product(s) : Orlistat
Therapeutic Area : Nutrition and Weight Loss
Highest Development Status : Undisclosed
Recipient : University of Campinas, Brazil
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Orlistat
Therapeutic Area : Nutrition and Weight Loss
Study Phase : Undisclosed
Recipient : University of Campinas, Brazil
Deal Size : Inapplicable
Deal Type : Inapplicable
Study of Fat Malabsorption by Lipiblock Versus Xenical
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
July 27, 2010
Lead Product(s) : Orlistat
Therapeutic Area : Nutrition and Weight Loss
Highest Development Status : Undisclosed
Recipient : University of Campinas, Brazil
Deal Size : Inapplicable
Deal Type : Inapplicable